ELITE Income Statement - TTM - Elite Diagnostic Limited

Income Statement (TTM)

Elite Diagnostic Limited Income Statement shows changes in income and expenses over a period of time. Income Statement data includes Sales and Revenue, Gross Profit, Research and Development (R&D), Selling, General and Administrative Expense (SG&A), Operating Income, Income Tax Expense, Interest Expense, Non-Operating Income, Earnings per Share (EPS), and Shares Outstanding.

All numbers are times 1,000,000 except per share units.

	2020 09-30	2020 12-31	2021 03-31	2021 06-30	2021 09-30	2021 12-31	2022 03-31	2022 06-30	2022 09-30	2022 12-31	2023 03-31	2023 06-30	2023 09-30	2023 12-31	2024 03-31	2024 06-30	2024 09-30	2024 12-31	2025 03-31	2025 06-30
Revenue	432	440	458	507	538	559	591	624	669	699	740	755	766	764	767	821	828	851	873	854
Change (%)		1.96	4.12	10.66	6.14	3.94	5.66	5.65	7.23	4.48	5.88	2.01	1.36	-0.24	0.38	7.12	0.81	2.79	2.58	-2.20
% of Revenue	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00

Cost Of Sales	180	176	180	201	208	211	212	224	225	235	258	277	284	273	262	278	280	284	278	211
Change (%)		-2.33	2.40	11.35	3.85	1.52	0.10	5.66	0.51	4.52	10.04	7.27	2.52	-4.04	-4.09	6.32	0.65	1.27	-1.98	-23.91
% of Revenue	41.73	39.97	39.31	39.55	38.70	37.80	35.81	35.82	33.57	33.59	34.91	36.71	37.13	35.71	34.12	33.86	33.81	33.31	31.83	24.76

Gross Operating Profit	251	264	278	306	330	348	379	401	445	464	482	478	481	491	505	543	548	568	595	642
Change (%)		5.03	5.26	10.22	7.63	5.47	9.04	5.64	10.98	4.46	3.78	-0.82	0.69	2.01	2.86	7.54	0.89	3.57	4.86	7.94
% of Revenue	58.27	60.03	60.69	60.45	61.30	62.20	64.19	64.18	66.43	66.41	65.09	63.29	62.87	64.29	65.88	66.14	66.19	66.69	68.17	75.24

SG&A	150	158	157	175	186	197	208	211	233	255	273	277	285	297	317	313	327	341	342	416
Change (%)		5.34	-0.39	11.21	6.54	5.90	5.50	1.26	10.81	9.38	6.93	1.42	2.97	4.20	6.85	-1.54	4.63	4.17	0.46	21.68
% of Revenue	34.71	35.86	34.31	34.48	34.61	35.26	35.21	33.75	34.87	36.51	36.87	36.66	37.24	38.90	41.40	38.06	39.50	40.03	39.20	48.77

R&D
Change (%)
% of Revenue

OpEx	426	436	447	477	499	515	521	542	577	620	680	691	709	706	701	726	742	767	780	798
Change (%)		2.54	2.35	6.85	4.46	3.24	1.26	3.92	6.57	7.31	9.69	1.62	2.59	-0.35	-0.66	3.50	2.28	3.36	1.58	2.36
% of Revenue	98.65	99.21	97.53	94.17	92.68	92.06	88.23	86.79	86.26	88.59	91.78	91.43	92.55	92.44	91.48	88.39	89.68	90.17	89.29	93.46

Operating Income	6	3	11	30	39	44	70	82	92	80	61	65	57	58	65	95	85	84	93	56
Change (%)		-40.67	227.68	161.00	33.14	12.77	56.60	18.56	11.56	-13.28	-23.70	6.33	-11.81	1.19	13.07	46.05	-10.39	-2.11	11.73	-40.24
% of Revenue	1.35	0.79	2.47	5.83	7.32	7.94	11.77	13.21	13.74	11.41	8.22	8.57	7.45	7.56	8.52	11.61	10.32	9.83	10.71	6.54

Interest Expense	-21	-20	-21	-21	-21	-22	-24	-27	-30	-32	-36	-33	-38	-42	-42	-49	-45	-42	-40	-36
Change (%)		-1.92	2.36	0.66	0.01	4.78	8.88	13.98	11.13	6.37	12.10	-9.79	17.13	8.81	0.51	16.22	-7.35	-5.98	-5.97	-10.32
% of Revenue	-4.82	-4.64	-4.56	-4.15	-3.91	-3.94	-4.06	-4.38	-4.54	-4.62	-4.89	-4.33	-5.00	-5.45	-5.46	-5.92	-5.44	-4.98	-4.56	-4.19

Net Income	-18	-20	-13	2	12	16	40	49	55	40	18	13	2	0	7	26	20	23	37	23
Change (%)		7.28	-32.38	-114.39	509.20	35.51	149.36	22.53	13.01	-26.58	-54.63	-27.11	-84.62	-82.11	1,779.13	278.90	-22.79	14.03	59.47	-38.68
% of Revenue	-4.28	-4.51	-2.93	0.38	2.18	2.85	6.72	7.80	8.22	5.77	2.47	1.77	0.27	0.05	0.90	3.18	2.44	2.71	4.21	2.64

Source: Capital IQ

Elite Diagnostic Limited - Income Statement (TTM)

Income Statement (TTM)